Want to see USNA full AI Analyst Report?
USNA Stock Chart & Stats
$13.54
-$0.22(-1.60%)
At close: 4:00 PM EDT
$13.54
-$0.22(-1.60%)
Day’s Range― - ―
52-Week Range$12.57 - $23.59
Previous Close$13.95
Volume291.12K
Average Volume (3M)183.55K
Market Cap
$262.74M
Enterprise Value$273.74M
Total Cash (Recent Filing)$168.56M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Nov 03, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.21
Shares Outstanding18,476,534
10 Day Avg. Volume188,115
30 Day Avg. Volume183,554
Financial Highlights & Ratios
PEG Ratio-0.46
Price to Book (P/B)0.68
Price to Sales (P/S)0.39
P/FCF Ratio42.35
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit0.39
Enterprise Value/Ebitda6.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.76
Revenue Forecast (FY)$909.00M
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet And LiquiditySubstantial cash, no debt, and positive free cash flow give USANA meaningful financial flexibility while profitability is under pressure. This liquidity can support product investment, retail expansion, and operating resilience without relying heavily on external financing.
Core Nutrition ResilienceThe core nutritional business remains an important stabilizing platform, with performance in line with expectations and renewed momentum in Mainland China. Product launches and incentive strength may support customer retention and provide a foundation for recovery across the broader portfolio.
Product And Retail ExpansionUSANA is expanding beyond its traditional distributor-led model through new products and broader retail access. National distribution for Protein Pop and Rise's planned footprint can increase consumer reach, diversify channels, and build recurring demand if execution remains consistent.
Bears Say
Severe Profitability DeteriorationProfitability has weakened sharply despite a strong gross margin, indicating that operating expenses and lower revenue efficiency are absorbing most product-level economics. Persistently thin EBIT and a net loss reduce internal reinvestment capacity and make earnings recovery dependent on successful cost and demand improvements.
Hiya Customer-acquisition PressureHigher digital customer-acquisition costs and platform algorithm changes threaten the scalability of Hiya's subscription model. Weaker subscriber growth can reduce recurring revenue leverage, require continued advertising investment, and prolong pressure on the venture's margins and valuation assumptions.
Broad Revenue And Customer ContractionThe decline in company-wide sales alongside lower customer and subscriber counts points to pressure on demand rather than only an isolated accounting item. Continued contraction could weaken operating leverage, limit the benefits of retail expansion, and make the lowered annual outlook harder to recover.
USANA Health News
USNA FAQ
What was USANA Health’s price range in the past 12 months?
USANA Health lowest stock price was $12.57 and its highest was $23.59 in the past 12 months.
What is USANA Health’s market cap?
USANA Health’s market cap is $262.74M.
When is USANA Health’s upcoming earnings report date?
USANA Health’s upcoming earnings report date is Nov 03, 2026 which is in 11 days.
How were USANA Health’s earnings last quarter?
USANA Health released its earnings results on Aug 04, 2026. The company reported -$0.07 earnings per share for the quarter, missing the consensus estimate of $0.43 by -$0.5.
Is USANA Health overvalued?
According to Wall Street analysts USANA Health’s price is currently Overvalued.
Does USANA Health pay dividends?
USANA Health does not currently pay dividends.
What is USANA Health’s EPS estimate?
USANA Health’s EPS estimate is 0.11.
How many shares outstanding does USANA Health have?
USANA Health has 18,476,534 shares outstanding.
What happened to USANA Health’s price movement after its last earnings report?
USANA Health reported an EPS of -$0.07 in its last earnings report, missing expectations of $0.43. Following the earnings report the stock price went down -34.197%.
Which hedge fund is a major shareholder of USANA Health?
Currently, no hedge funds are holding shares in USNA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
USANA Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
USNA Sentiment 50%
Sector Average 64%
Sector Average 64%
Hedge Fund Trend
Increased
By 92.7K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.38%
12-Months-Change
Fundamentals
Return on Equity
-4.16%
Trailing 12-Months
Asset Growth
-4.26%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
USANA Health
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
USNA Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced clear strategic progress (strong balance sheet, stable core nutrition, successful new product launches, and retail expansion for Hiya and Rise) with meaningful near-term operational and financial headwinds (a $29M goodwill impairment for Hiya, a quarterly pre-tax loss with a $9M tax charge, lowered full-year outlook, Hiya DTC marketing pressures, and a Rise packaging disruption). Management emphasized long-term conviction and the ability to invest, but acknowledged near-term impacts to revenue, margins, and tax rates.View all USNA earnings summariesTechnical Analysis
Herbalife
―
Natural Alternatives International
―
Nature's Sunshine Products
―
LifeVantage
―
FitLife Brands
―
Ownership Overview
0.66% Insiders
10.57% Mutual Funds
0.24% Other Institutional Investors
74.33% Public Companies and
Individual Investors